Brainstorm Cell Therapeutics, Inc (NASDAQ: BCLI) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 7.91M common shares owned by the public and among those 6.17M shares have been available to trade. The company’s stock has a 5-day price change of 11.48% and -26.09% over the past three months. BCLI shares are trading -40.09% year to date (YTD), with the 12-month market performance down to -81.27% lower. […]
Is Brainstorm Cell Therapeutics, Inc (NASDAQ: BCLI) Proving The Doubters Wrong?
Brainstorm Cell Therapeutics, Inc (BCLI) concluded trading on Thursday at a closing price of $0.91, with 5.98 million shares of worth about $5.44 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.51% during that period and on April 10, 2025 the price saw […]
These Numbers Could Change Investor Views For Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI)
Liberty Wealth Management LLC recently announced the acquisition of new stake in Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI). The institutional investor has increased its shareholding in the Healthcare company by 134.22% to 0.35 million shares with purchase of 0.2 million shares. This fresh investment now brings its stake to 0.72% valued currently at $98381.0. In addition, […]
